Reactogenicity and Humoral Immune Response after Heterologous Vaxzevria/Comirnaty Vaccination in a Group of Individuals Vaccinated in the AOU Policlinic “G. Martino” (Messina, Italy): A Retrospective Cohort Study

On 11 June 2021, the Italian Ministry of Health authorized the heterologous vaccination schedule. The goals of our retrospective study were to (a) evaluate the undesirable effects after the administration of Vaxzevria and Comirnaty vaccines; (b) evaluate the antibody response after 28 days from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Venuto, Roberto, Giunta, Ioselita, Vaccaro, Mario, La Fauci, Vincenza, Ceccio, Concetta, Fedele, Francesco, Privitera, Antonino, Denaro, Federica, Pantò, Giuseppe, Cortese, Rosaria, Visalli, Giovanna, D’Amato, Smeralda, Squeri, Andrea, Squeri, Raffaele, Genovese, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697593/
https://www.ncbi.nlm.nih.gov/pubmed/36366314
http://dx.doi.org/10.3390/vaccines10111803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697593/
https://www.ncbi.nlm.nih.gov/pubmed/36366314
http://dx.doi.org/10.3390/vaccines10111803

Ejemplares similares